Guangdong Taienkang Pharmaceutical Co., Ltd (SZSE:301263) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The repurchase price will not be more than CNY 25 per share. The repurchased shares will be used for ESOP or equity incentives. The program is valid for 12 months.

On May 23, 2024, the company amended its share repurchase program. The shares will be repurchased at a price not exceeding CNY 24.7 per share.